1Lund RH, Moritz MW, Complications of Denver peritoneovenous shunting. Arch Surg, 1982, 117:924-928.
2Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology, 1996, 23:164.
3LeVeen HH, Christoudias G, Ip M, et al. Peritoneo-venous shunting for ascites. Ann Surg, 1974, 180:580-591.
4Agarwal S, Joyner KA Jr, Swaim MW. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol,2000, 95:3218-3224.
5Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology, 1996, 23: 164.
6Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patient admitted to the hospital for the treatment of ascites. Gastroenterology, 1988, 94:482.
7Salemo F, Borroni G, Moser P, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol, 1993, 88:514-519.
8LeVeen HH, Christoudias G, Ip M, et al. Peritoneovenous shunting for ascites. Ann Surg, 1974, 180:580 591.
9Akimaru K, Ueda Y, Shoji T. Peritoneovenous shunting for intractable cirrhotic and cancerous ascites using different types of shunting tubes. Jpn J Surg, 1988, 18:502 508.
10Lund RH, Moritz MW. Complications of Denver peritoneovenous shunting. Arch Surg, 1982, 117: 924-928.
